VEGF is one of the key regulators of angiogenesis, vasculogenesis, and developmental hematopoiesis. It is a mitogen and survival factor for vascular endothelial cells while also promoting vascular endothelial cell and monocyte motility[1]. Binding of growth factors to the ectodomain of their transmembrane receptors leads to receptor dimerization, protein kinase activation, trans-autophosphorylation, and initiation of signaling pathways. The VEGF family of receptors (RTK class IV, VEGF receptor family) consists of three protein–tyrosine kinases (VEGFR1, VEGFR2, and VEGFR3) and two non-protein kinase co-receptors (neuropilin-1 and 2)[2]. Targeting VEGF receptors proved to be a successful therapeutic approach for disorders with non-physiologic angiogenesis including age-related macular degeneration of the eye, diabetic retinopathy, rheumatoid arthritis, tumor growth and metastasis1.

[1] Vascular endothelial growth factor (VEGF) signaling during tumor progression. A comprehensive review of the discovery of the VEGF family of ligands and receptors. R. Roskoski Jr. Crit. Rev. Oncol. Hematol. 2007, 62, 179–213.
[2] VEGF receptor protein–tyrosine kinases: Structure and regulation. Mini Review. R. Roskoski Jr. Biochem. Biophys. Res. Com. 2008, 375, 287–291.

14 Item(s)

per page
Axon ID Name Description From price
1978 ZM 323881 hydrochloride Inhibitor of VEGFR2 €105.00
1637 Vatalanib VEGFR tyrosine kinase inhibitor €75.00
1717 Tivozanib VEGFR1, 2, and 3 tyrosine kinase inhibitor €80.00
3338 Taxifolin Inhibitor of VEGFR2 €50.00
2865 NVP-ACC789 Inhibitor of VEGFR2 €90.00
3998 MGCD516 Orally bioavailable receptor tyrosine kinase (RTK) inhibitor Inquire
1963 LY 573636 Anti-tumor agent; causes growth arrest and apoptosis €80.00
3165 Lenvatinib Multi-targeted receptor tyrosine kinase inhibitor €70.00
1662 CP 547632 VEGFR2 tyrosine kinase inhibitor €70.00
1461 Cediranib VEGFR tyrosine kinase inhibitor €70.00
1864 Brivanib alaninate Prodrug of BMS 540215; Inhibitor of VEGF €90.00
2837 BMS 605541 Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor €90.00
1850 BMS 540215 Inhibitor of VEGFR (subtype 2 and 3 selective) €110.00
2849 Apatinib Inhibitor of VEGFR2 €120.00

14 Item(s)

per page
Please wait...